MME
BSX icon

Meag Munich Ergo’s Boston Scientific BSX Stock Holding History

Meag Munich Ergo’s Portfolio BSX Stock Details BSX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-21,183
Closed -$953K – 246
2019
Q4 		$953K Sell
21,183
-69,497
-77% -$2.91M 0.1% 200
2019
Q3 		$3.64M Buy
90,680
+38,715
+75% +$1.64M 0.19% 120
2019
Q2 		$2.18M Hold
51,965
– – 0.17% 133
2019
Q1 		$1.97M Buy
51,965
+7,520
+17% +$287K 0.16% 146
2018
Q4 		$1.54M Sell
44,445
-39,296
-47% -$1.43M 0.19% 138
2018
Q3 		$3.19M Sell
83,741
-5,692
-6% -$199K 0.19% 154
2018
Q2 		$2.93M Buy
+89,433
New +$2.7M 0.18% 167
2018
Q1 		– Sell
-65,713
Closed -$1.67M – 405
2017
Q4 		$1.67M Buy
+65,713
New +$1.81M 0.06% 303

Other funds holding BSX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
BG
Bollard Group Boston, Massachusetts $3.39B AUM 1.06% 1-Year Est. Return

Meag Munich Ergo's BSX Position: Q1 2020 in Review

Meag Munich Ergo sold out of Boston Scientific (BSX) in Q1 2020, closing a stake of 21,183 shares — an estimated $953K sold.

Meag Munich Ergo first reported a position in BSX in Q4 2017 and held it in 8 quarters. The position peaked at $3.64M in Q3 2019. 800 funds tracked by Wall St. Rank hold BSX as of Q1 2020.

  • Meag Munich Ergo reported no remaining Boston Scientific position as of Q1 2020 after selling out during the quarter.
  • Meag Munich Ergo sold 21,183 Boston Scientific shares in Q1 2020, an estimated $953K.
  • Meag Munich Ergo first reported a position in Boston Scientific in Q4 2017 and held it in 8 quarters.
  • Meag Munich Ergo's Boston Scientific position peaked at $3.64M in Q3 2019.
  • 800 funds tracked by Wall St. Rank held Boston Scientific as of Q1 2020.

Based on Meag Munich Ergo's 13F filing for Q1 2020, filed 23 Apr 2020.